乙氨基对神经发育的危害超过了对长期益处的有限证据
William Parker1,2,3, Lauren G Anderson2, John P Jones2
1Department of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC 27599, USA.
Children (Basel, Switzerland)
|January 23, 2024
概括
婴儿和儿童暴露于乙氨基 (偏醇) 与自闭症谱系障碍 (ASD) 有关. 产后早期暴露是最大的风险,可能导致90%以上的自闭症病例.
科学领域:
- 神经科学是一个神经科学.
- 发育儿科 发育儿科
- 毒理学 毒理学 毒理学
背景情况:
- 乙氨基 (偏醇) 广泛用于缓解儿童疼痛和发烧.
- 新出现的证据表明,与乙氨基暴露相关的潜在神经发育风险.
- 自闭症谱系障碍 (ASD) 的患病率有所增加,促使对环境因素的调查.
研究的目的:
- 评估将乙氨基暴露与自闭症谱系障碍 (ASD) 相关的证据.
- 估计可能由乙氨基引起的ASD病例的比例.
- 为了确定乙氨基诱导风险的关键神经发育时期.
主要方法:
- 审查现有数据,包括动物研究,人类观察,时间相关性和毒理学数据.
- 对乙氨基对成人社会意识的影响的分析.
- 估计不同神经发育阶段的乙氨基诱导的ASD病例.
主要成果:
- 强有力的证据表明,乙氨基暴露会诱导许多自闭症病例.
- 产后早期被确定为乙氨基诱导的ASD风险最高的窗口.
- 在早期发育期间使用乙氨基可能占自闭症病例的90%以上.
- 在儿科群体中,经常过度使用和没有明显益处的药物被注意到.
结论:
- 乙氨基对神经发育构成重大风险,并与自闭症谱系障碍有关.
- 在早期发育中对乙氨基的广泛使用要求重新评估其儿科应用.
- 没有证明儿科使用的长期益处超过神经发育风险.
更多相关视频
相关概念视频
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Attention-Deficit/Hyperactivity Disorder
68
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
68
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
304
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
304
Local Anesthetics: Adverse Effects
416
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
416
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
148
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
148
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K


